title: Recurrent idiopathic membranous glomerulonephritis after kidney transplantation and successful treatment with rituximab.
abstract: After renal transplantation approximately forty percent of patients with membranous glomerolunephritis (MGN) had a recurrence, most commonly during the first year.We present two cases with recurrent MGN after kidney transplantation who successfully treated with ritoximab.
authors: Nephrology and Renal Transplant Center, Urmia University of Medical Sciences, Urmia, Iran. makhdoomikhadijeh@yahoo.com.
authors: Khadijeh
authors: K
authors: Makhdoomi
authors: Saeed
authors: S
authors: Abkhiz
authors: Farahnaz
authors: F
authors: Noroozinia
authors: Azam
authors: A
authors: Mivefroshan
authors: Javad
authors: J
authors: Zeinali
authors: Lale
authors: L
authors: Jafari
authors: Lale
authors: L
authors: Jafari
authors: Abbas
authors: A
authors: Saffarifard
mesh_terms: D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D000069283:Rituximab / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D000069283:Rituximab